Literature DB >> 21291473

S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling.

Alejandro Villarreal1, Rolando X Aviles Reyes, Maria Florencia Angelo, Analia G Reines, Alberto Javier Ramos.   

Abstract

S100B is a soluble protein secreted by astrocytes that exerts pro-survival or pro-apoptotic effects depending on the concentration reached in the extracellular millieu. The S100B receptor termed RAGE (for receptor for advanced end glycation products) is highly expressed in the developing brain but is undetectable in normal adult brain. In this study, we show that RAGE expression is induced in cortical neurons of the ischemic penumbra. Increased RAGE expression was also observed in primary cortical neurons exposed to excitotoxic glutamate (EG). S100B exerts effects on survival pathways and neurite extension when the cortical neurons have been previously exposed to EG and these S100B effects were prevented by anti-RAGE blocking antibodies. Furthermore, nuclear factor kappa B (NF-κB) is activated by S100B in a dose- and RAGE-dependent manner and neuronal death induced by NF-κB inhibition was prevented by S100B that restored NF-κB activation levels. Together, these findings suggest that excitotoxic damage can induce RAGE expression in neurons from ischemic penumbra and demonstrate that cortical neurons respond to S100B through engagement of RAGE followed by activation of NF-κB signaling. In addition, basal NF-κB activity in neurons is crucial to modulate the extent of pro-survival or pro-death S100B effects.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21291473     DOI: 10.1111/j.1471-4159.2011.07207.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  33 in total

Review 1.  The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.

Authors:  W K Jo; A C K Law; S K Chung
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

2.  The metastasis-promoting S100A4 protein confers neuroprotection in brain injury.

Authors:  Oksana Dmytriyeva; Stanislava Pankratova; Sylwia Owczarek; Katrin Sonn; Vladislav Soroka; Christina M Ridley; Alexander Marsolais; Marcos Lopez-Hoyos; Noona Ambartsumian; Eugene Lukanidin; Elisabeth Bock; Vladimir Berezin; Darya Kiryushko
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

3.  Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma.

Authors:  Liguo Lin; Kaihua Zhong; Zhongkai Sun; Guozhong Wu; Guodong Ding
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-24       Impact factor: 4.553

4.  Normal cerebellar development in S100B-deficient mice.

Authors:  Björn Bluhm; Björn Laffer; Daniela Hirnet; Matthias Rothermundt; Oliver Ambree; Christian Lohr
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

5.  S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis.

Authors:  Andreia Barateiro; Vera Afonso; Gisela Santos; João José Cerqueira; Dora Brites; Jack van Horssen; Adelaide Fernandes
Journal:  Mol Neurobiol       Date:  2015-07-17       Impact factor: 5.590

6.  Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) Activation Balance Astrocyte Polarization into a Proinflammatory Phenotype.

Authors:  Gerardo Rosciszewski; Vanesa Cadena; Veronica Murta; Jeronimo Lukin; Alejandro Villarreal; Thierry Roger; Alberto Javier Ramos
Journal:  Mol Neurobiol       Date:  2017-05-25       Impact factor: 5.590

7.  miR-146a-5p Antagonized AGEs- and P.g-LPS-Induced ABCA1 and ABCG1 Dysregulation in Macrophages via IRAK-1 Downregulation.

Authors:  Xia Li; Zheng Ji; Si Li; Ya-Nan Sun; Jia Liu; Ying Liu; Wei Tian; Yun-Tao Zhou; Xiao-Ming Shang
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

8.  S100B inhibition reduces behavioral and pathologic changes in experimental traumatic brain injury.

Authors:  Shruti V Kabadi; Bogdan A Stoica; Danna B Zimmer; Lauriaselle Afanador; Kara B Duffy; David J Loane; Alan I Faden
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-08       Impact factor: 6.200

9.  Cross-talk between neurons and astrocytes in response to bilirubin: early beneficial effects.

Authors:  Ana Sofia Falcão; Rui F M Silva; Ana Rita Vaz; Sandra Leitão Silva; Adelaide Fernandes; Dora Brites
Journal:  Neurochem Res       Date:  2013-01-03       Impact factor: 3.996

Review 10.  Is RAGE still a therapeutic target for Alzheimer's disease?

Authors:  Richard J Deane
Journal:  Future Med Chem       Date:  2012-05       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.